EPC1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.181000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.294200E-01
Normal-vs-Stage2
6.884700E-03
Normal-vs-Stage3
1.416760E-01
Normal-vs-Stage4
3.818400E-01
Stage1-vs-Stage2
2.362600E-01
Stage1-vs-Stage3
2.084500E-02
Stage1-vs-Stage4
9.147400E-01
Stage2-vs-Stage3
8.009700E-02
Stage2-vs-Stage4
2.691000E-01
Stage3-vs-Stage4
5.757500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.679200E-03
Normal-vs-AfricanAmerican
3.761600E-01
Normal-vs-Asian
1.578360E-02
Caucasian-vs-AfricanAmerican
8.822500E-02
Caucasian-vs-Asian
1.639410E-01
AfricanAmerican-vs-Asian
4.639800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.697500E-03
Normal-vs-Female
8.599300E-03
Male-vs-Female
5.110000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.726000E-01
Normal-vs-Age(41-60Yrs)
3.741700E-02
Normal-vs-Age(61-80Yrs)
3.737700E-03
Normal-vs-Age(81-100Yrs)
2.076000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.340600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.176400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.674000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.124020E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.588400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.363600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.223500E-03
Normal-vs-Daily Drinker
2.896500E-03
Normal-vs-Weekly Drinker
1.219670E-02
Normal-vs-Occasional Drinker
2.585800E-01
Normal-vs-Social Drinker
8.850100E-02
Non Drinker-vs-Daily Drinker
6.714400E-01
Non Drinker-vs-Weekly Drinker
8.941000E-01
Non Drinker-vs-Occasional Drinker
3.756200E-01
Non Drinker-vs-Social Drinker
1.349650E-01
Daily Drinker-vs-Weekly Drinker
8.176400E-01
Daily Drinker-vs-Occasional Drinker
1.929040E-01
Daily Drinker-vs-Social Drinker
7.211700E-02
Weekly Drinker-vs-Occasional Drinker
3.584200E-01
Weekly Drinker-vs-Social Drinker
1.711010E-01
Occasional Drinker-vs-Social Drinker
4.695400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.456100E-02
Normal-vs-Grade 2
1.805740E-02
Normal-vs-Grade 3
1.691640E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.823000E-01
Grade 1-vs-Grade 3
8.896200E-01
Grade 1-vs-Grade 4
7.456100E-02
Grade 2-vs-Grade 3
9.900000E-01
Grade 2-vs-Grade 4
1.805740E-02
Grade 3-vs-Grade 4
1.691640E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.958000E-03
Normal-vs-NonDiabetic
2.339600E-01
Diabetic-vs-NonDiabetic
9.190000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.225600E-01
Normal-vs-NoPancreatitis
2.744300E-03
Pancreatitis-vs-NoPancreatitis
6.239400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.704160E-02
Normal-vs-N1
6.375300E-03
N0-vs-N1
7.419400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.902000E-01
Normal-vs-TP53-NonMutant
1.254220E-01
TP53-Mutant-vs-TP53-NonMutant
2.906000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
